{"id":"https://openalex.org/W2561480452","doi":"https://doi.org/10.1182/blood.v120.21.2642.2642","title":"A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.","display_name":"A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2561480452","doi":"https://doi.org/10.1182/blood.v120.21.2642.2642","mag":"2561480452"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.2642.2642","doi":"https://doi.org/10.1182/blood.v120.21.2642.2642","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.2642.2642","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049271789","display_name":"Karin Boslooper","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802652803","display_name":"Medisch Centrum Leeuwarden","ror":"https://ror.org/0283nw634","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802652803","https://openalex.org/I4405259012"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Karin Boslooper","raw_affiliation_strings":["Internal Medicine, Medical Centre Leeuwarden (MCL), Leeuwarden, Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Medical Centre Leeuwarden (MCL), Leeuwarden, Netherlands,","institution_ids":["https://openalex.org/I2802652803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110068950","display_name":"Peter Joosten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802652803","display_name":"Medisch Centrum Leeuwarden","ror":"https://ror.org/0283nw634","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802652803","https://openalex.org/I4405259012"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Peter Joosten","raw_affiliation_strings":["Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands,","institution_ids":["https://openalex.org/I2802652803"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045583556","display_name":"Nic J.G.M. Veeger","orcid":"https://orcid.org/0000-0002-1492-7937","observed_orcids":["https://orcid.org/0000-0002-1492-7937"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Nic J.G.M. Veeger","raw_affiliation_strings":["Department of Hematology, University Medical Center Groningen, Groningen, Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University Medical Center Groningen, Groningen, Netherlands,","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110940042","display_name":"Robby E. Kibbelaar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155135","display_name":"Helse F\u00f8rde","ror":"https://ror.org/05dzsmt79","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I4210155135"]}],"countries":["NO"],"is_corresponding":true,"raw_author_name":"Robby Kibbelaar","raw_affiliation_strings":["Pathology, Pathology Friesland, Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Pathology Friesland, Netherlands,","institution_ids":["https://openalex.org/I4210155135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110579470","display_name":"Eric van Roon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Eric van Roon","raw_affiliation_strings":["Zorggroep Noorderbreedte, Leeuwarden, Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Zorggroep Noorderbreedte, Leeuwarden, Netherlands,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011657059","display_name":"Sjoerd Hovenga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118985","display_name":"Ziekenhuis Nij Smellinghe","ror":"https://ror.org/030gj2p37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210118985"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Sjoerd Hovenga","raw_affiliation_strings":["Internal Medicine / Hematology, Nij Smellinghe, Drachten, Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine / Hematology, Nij Smellinghe, Drachten, Netherlands,","institution_ids":["https://openalex.org/I4210118985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089804114","display_name":"Gerhard Woolthuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405260767","display_name":"Antonius Ziekenhuis","ror":"https://ror.org/0489xrh07","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4405260767"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Gerhard Woolthuis","raw_affiliation_strings":["Antonius Hospital, Sneek, Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antonius Hospital, Sneek, Netherlands,","institution_ids":["https://openalex.org/I4405260767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042799541","display_name":"Hanneke C. Kluin\u2010Nelemans","orcid":"https://orcid.org/0000-0003-2617-9427","observed_orcids":["https://orcid.org/0000-0003-2617-9427"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hanneke C. Kluin-Nelemans","raw_affiliation_strings":["Hematology, University Medical Centre Groningen, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, University Medical Centre Groningen, Groningen, Netherlands","institution_ids":["https://openalex.org/I1334415907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027058055","display_name":"Mels Hoogendoorn","orcid":"https://orcid.org/0000-0001-8032-2592","observed_orcids":["https://orcid.org/0000-0001-8032-2592"]},"institutions":[{"id":"https://openalex.org/I2802652803","display_name":"Medisch Centrum Leeuwarden","ror":"https://ror.org/0283nw634","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802652803","https://openalex.org/I4405259012"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Mels Hoogendoorn","raw_affiliation_strings":["Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands,","institution_ids":["https://openalex.org/I2802652803"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5011657059","https://openalex.org/A5027058055","https://openalex.org/A5045583556","https://openalex.org/A5049271789","https://openalex.org/A5089804114","https://openalex.org/A5110579470","https://openalex.org/A5110940042"],"corresponding_institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I2802652803","https://openalex.org/I4210118985","https://openalex.org/I4210155135","https://openalex.org/I4405260767"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.40714742,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"120","issue":"21","first_page":"2642","last_page":"2642"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/very-elderly-patients","display_name":"very elderly patients","score":0.890999972820282},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.753000020980835},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9620000123977661},{"id":"https://openalex.org/keywords/2-year-survival","display_name":"two-year survival","score":0.6940000057220459},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.7799999713897705},{"id":"https://openalex.org/keywords/frailty","display_name":"frailty","score":0.5770000219345093},{"id":"https://openalex.org/keywords/palliative-radiotherapy","display_name":"palliative radiotherapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/supportive-care","display_name":"supportive care","score":0.8009999990463257},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7699999809265137},{"id":"https://openalex.org/keywords/international-prognostic-index","display_name":"International Prognostic Index","score":0.902999997138977},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.3109999895095825},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.36000001430511475},{"id":"https://openalex.org/keywords/friesland","display_name":"Friesland","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8472580909729004},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6172404885292053},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5997917056083679},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5769588947296143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5529447793960571},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5240048170089722},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40249624848365784},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3315064013004303},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.2657025456428528},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1182/blood.v120.21.2642.2642","doi":"https://doi.org/10.1182/blood.v120.21.2642.2642","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.2642.2642","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/eefaf4ef-ac9f-4d9c-bbe2-82b1464007ae","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/eefaf4ef-ac9f-4d9c-bbe2-82b1464007ae","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Boslooper, K, Joosten, P, Veeger, N J G M, Kibbelaar, R, van Roon, E, Hovenga, S, Woolthuis, G, Kluin-Nelemans, H C & Hoogendoorn, M 2012, 'A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy : A Population-Based Cohort Study On Treatment, Toxicity and Outcome', Blood, vol. 120, no. 21.","raw_type":"article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/6e727fd7-9988-41a1-a4c9-58b3ee9e50e1","doi":null,"is_oa":false,"landing_page_url":"https://www.rug.nl/research/portal/en/publications/a-significant-better-two-year-survival-in-the-very-elderly-patients-with-a-diffuse-large-bcell-lymphoma-dlbcl-who-did-complete-standard-therapy(6e727fd7-9988-41a1-a4c9-58b3ee9e50e1).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 120(21)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/b8c6490f-6647-4d31-8574-8739919f08da","doi":null,"is_oa":false,"landing_page_url":"https://www.rug.nl/research/portal/en/publications/a-significant-better-two-year-survival-in-the-very-elderly-patients-with-a-diffuse-large-bcell-lymphoma-dlbcl-who-did-complete-standard-therapy(b8c6490f-6647-4d31-8574-8739919f08da).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 120(21)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/eefaf4ef-ac9f-4d9c-bbe2-82b1464007ae","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/eefaf4ef-ac9f-4d9c-bbe2-82b1464007ae","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 120(21). AMER SOC HEMATOLOGY","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2126086632","https://openalex.org/W2027034964","https://openalex.org/W2980601990","https://openalex.org/W2460811036","https://openalex.org/W3031593977","https://openalex.org/W3034704434","https://openalex.org/W2912038736","https://openalex.org/W4210888659","https://openalex.org/W4285730406","https://openalex.org/W2809084663"],"abstract_inverted_index":{"Abstract":[0,1],"2642":[2],"Introduction":[3],"With":[4],"the":[5,8,23,29,45,50,94,129,156,224,324,352,399,445,481,530,606,617,626],"aging":[6],"of":[7,31,62,135,150,159,226,275,314,319,335,345,367,412,434,454,527,532,628,647],"population":[9],"clinicians":[10],"are":[11,34,47,120],"increasingly":[12],"confronted":[13],"with":[14,19,91,109,117,142,236,249,326,339,361,381,416,438,466,468,490,518,536,546,566,594,641],"elderly,":[15],"often":[16,35],"frail,":[17],"patients":[18,86,107,137,229,277,285,296,303,325,355,376,396,403,413,420,436,464,533,640],"a":[20,70,110,115,126,143,148,217,237,250,340,362,382,507,519,525,537,547,567,601,629],"DLBCL.":[21,238,642],"While":[22],"very":[24,638],"elderly":[25,482,608,639],"patients,":[26,69,593],"defined":[27],"by":[28,216],"age":[30,241,306,514],"\u226575":[32,88],"year,":[33,89],"excluded":[36],"from":[37,155,613,616],"clinical":[38,160],"trials,":[39],"only":[40,187,422,599],"few":[41],"prospective":[42],"data":[43,134],"in":[44,52,67,84,93,113,125,176,283,294,394,432,463,534,591,637],"rituximab-era":[46],"available":[48],"on":[49,79],"outcome":[51,83,169],"this":[53,132,349,553],"patient":[54,622],"cohort.":[55],"To":[56],"asses":[57],"efficacy,":[58],"tolerability":[59],"and":[60,82,101,123,163,168,186,266,293,337,496,512,539,549],"safety":[61],"standard":[63,383],"intensive":[64,561,614],"rituximab-containing":[65,182,439],"therapy":[66,384,511],"those":[68,270,488,499],"descriptive":[71],"population-based,":[72],"cohort":[73],"study":[74],"was":[75,98,174,191,201,242,259,291,299,311,392,414,425,444,478,515,544,563,588],"performed.":[76],"Detailed":[77],"information":[78],"treatment,":[80],"toxicity":[81,167,428,587],"all":[85,106,136,435],"aged":[87,138,230,540],"diagnosed":[90,108,145,235],"DLBCL":[92,146,538],"Dutch":[95],"province":[96,116],"Friesland":[97,535],"prospectively":[99,121],"gathered":[100],"analyzed.":[102],"Methods":[103],"Since":[104],"2005":[105,222],"haematological":[111],"malignancy":[112],"Friesland,":[114],"600.000":[118],"inhabitants,":[119],"registered":[122],"followed":[124],"population-based":[127],"registry,":[128],"HemobaseR.":[130,157],"For":[131],"analysis":[133,509],"\u2265":[139,231,541],"75":[140,232,246,542],"years":[141,152,233,244,529,543],"newly":[144],"over":[147],"period":[149,258,526],"six":[151,372,452,528],"were":[153,170,214,234,461],"retrieved":[154],"Data":[158],"characteristics,":[161],"treatment":[162,562],"its":[164],"adaptations,":[165],"treatment-related":[166,586],"obtained.":[171],"Treatment":[172],"modality":[173],"divided":[175],"four":[177],"groups:":[178],"R-CHOP":[179,336,359,548],"chemotherapy,":[180,409,485],"other":[181,353],"therapy,":[183,615],"palliative":[184,501,579],"radiotherapy":[185,338,502,580],"supportive":[188,423,504,582],"care.":[189,505],"Follow-up":[190],"completed":[192,369,386,484],"until":[193,223],"31":[194,267,365],"December":[195],"2011.":[196],"Cox":[197],"Proportional":[198],"hazards":[199],"model":[200],"used":[202],"for":[203,211,269,448,480,487,498,621],"identifying":[204],"significant":[205],"prognostic":[206],"risk":[207],"factors.":[208],"Kaplan-Meier":[209],"curves":[210],"each":[212],"group":[213,401],"evaluated":[215,636],"logrank":[218],"test.":[219],"Results":[220],"From":[221],"end":[225],"2011":[227],"103":[228],"The":[239,255,475,555],"median":[240,256],"81":[243],"(range":[245,262],"\u2013":[247,264],"96)":[248],"slight":[251],"female":[252],"predominance":[253],"(57%).":[254],"observation":[257],"13":[260,330],"months":[261,268],"1":[263,281,328],"78)":[265],"still":[271],"alive":[272],"at":[273,370],"time":[274],"evaluation.19":[276],"(19%)":[278],"had":[279,316],"stage":[280,327],"disease;":[282],"74":[284],"(71%)":[286],"advanced":[287],"disease":[288],"(stage":[289],"2\u20134)":[290],"reported":[292],"10":[295,402],"(10%)":[297,404],"staging":[298],"incomplete.":[300],"In":[301,398,418,506],"84":[302,354],"(81%)":[304],"an":[305,317,560],"adjusted":[307],"International":[308],"Prognostic":[309],"Index":[310],"calculated,":[312],"43%":[313],"them":[315,346,368],"aaIPI":[318],"2":[320],"or":[321,492,503,577,581],"3.":[322],"Of":[323,351],"disease,":[329],"(68%)":[331,357],"received":[332,358,405],"three":[333],"courses":[334],"curative":[341,363],"intent.":[342,364],"Eight":[343],"(62%)":[344],"did":[347,379],"complete":[348,390,552,558],"therapy.":[350],"57":[356],"chemotherapy":[360,455,494,575],"(54%)":[366],"least":[371],"cycles.":[373],"Ultimately":[374],"39":[375],"(56%),":[377],"who":[378,483,610],"start":[380],"regimen,":[385],"their":[387],"treatment.":[388,554],"A":[389],"remission":[391],"achieved":[393],"30":[395],"(77%).":[397],"remaining":[400],"alternative,":[406],"suboptimal,":[407],"rituximab-based":[408],"9":[410],"(9%)":[411],"treated":[415,437,465,489,545],"radiotherapy.":[417],"12":[419],"(11%)":[421],"care":[424,583],"given.":[426],"Severe":[427,585],"(grade":[429],"3\u20134),":[430],"occurred":[431],"66%":[433,592],"chemotherapy.":[440],"Toxicity":[441],"grade":[442],"3\u20134":[443],"main":[446],"reason":[447],"receiving":[449,500],"less":[450],"then":[451],"cycles":[453],"(44%).":[456],"Ten":[457],"toxicity-related":[458,596],"deaths":[459,470],"(13%)":[460],"observed":[462,590],"R-CHOP,":[467],"eight":[469],"due":[471],"to":[472,557,573,604,649],"infectious":[473],"complications.":[474],"two-year":[476],"survival":[477,521,570],"67%":[479],"25%":[486],"incomplete":[491],"inferior":[493],"regimens":[495],"20%":[497],"multivariate":[508],"completing":[510],"not":[513],"significantly":[516,564],"associated":[517,565],"better":[520,568],"(p<0.001).":[522],"Conclusion":[523],"Over":[524],"majority":[531],"56%":[550],"could":[551],"ability":[556],"such":[559,624],"2-years":[569],"(67%)":[571],"compared":[572],"suboptimal":[574],"(25%)":[576],"either":[578],"(20%).":[584],"also":[589],"13%":[595],"deaths.":[597],"Age":[598],"is":[600],"poor":[602],"indicator":[603],"differentiate":[605],"fit":[607],"patient,":[609],"will":[611],"benefit":[612],"frail.":[618],"Other":[619],"strategies":[620],"selection,":[623],"as":[625],"implication":[627],"comprehensive":[630],"geriatric":[631],"assessment,":[632],"should":[633],"be":[634],"further":[635],"Disclosures:":[643],"No":[644],"relevant":[645],"conflicts":[646],"interest":[648],"declare.":[650]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-06T00:00:00"}